The design of potent, non-peptidic inhibitors of hepatitis C protease
- 9 April 2003
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 38 (4) , 339-343
- https://doi.org/10.1016/s0223-5234(03)00050-3
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Hepatitis C virus NS3/4A proteaseAntiviral Research, 1998
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis CNew England Journal of Medicine, 1998
- Therapy of Viral HepatitisDigestion, 1998
- Hepatitis CThe Lancet, 1998
- Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis CThe Lancet, 1998
- Therapy of hepatitis C: Alpha interferon and ribavirinHepatology, 1997
- Epidemiology of hepatitis CHepatology, 1997
- Hepatitis C: The clinical spectrum of diseaseHepatology, 1997
- Relation of hepatitis C virus to hepatocellular carcinomaJournal of Hepatology, 1993